ロード中...
Economic evaluations of neuraminidase inhibitors to control influenza
Up to 10% of individuals present influenza-like illness each year. Neuraminidase inhibitors reduce significantly the median duration of flu symptoms by 1.38 days and median time to return to normal activities by 0.9 days in adults. This review presents the economic evaluations of neuraminidase inhib...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Future Drugs Ltd
2003
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3371228/ https://ncbi.nlm.nih.gov/pubmed/19807362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737167.3.2.147 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|